Literature DB >> 18710370

Ajuba: a new microtubule-associated protein that interacts with BUBR1 and Aurora B at kinetochores in metaphase.

Alexia Ferrand1, Véronique Chevrier, Jean-Paul Chauvin, Daniel Birnbaum.   

Abstract

BACKGROUND INFORMATION: The role of the LIM-domain-containing protein Ajuba was initially described in cell adhesion and migration processes and recently in mitosis as an activator of the Aurora A kinase.
RESULTS: In the present study, we show that Ajuba localizes to centrosomes and kinetochores during mitosis. This localization is microtubule-dependent and Ajuba binds microtubules in vitro. A microtubule regrowth assay showed that Ajuba follows nascent microtubules from centrosomes to kinetochores. Owing to its contribution to mitotic commitment and its microtubule-dependent localization, Ajuba could also play a role during the metaphase-anaphase transition. We show that Ajuba interacts with Aurora B and BUBR1 [BUB (budding uninhibited by benomyl)-related 1], two major components of the mitotic checkpoint. Inhibition of BUBR1 by siRNA (small interfering RNA) disrupts chromosome alignment at the metaphase plate and modifies Ajuba localization due to premature mitotic exit.
CONCLUSIONS: Ajuba is a microtubule-associated protein that collaborates with Aurora B and BUBR1 at the metaphase-anaphase transition and this may be important to ensure proper chromosome segregation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18710370     DOI: 10.1042/BC20080060

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  11 in total

1.  Role of senescence and mitotic catastrophe in cancer therapy.

Authors:  Richa Singh; Jasmine George; Yogeshwer Shukla
Journal:  Cell Div       Date:  2010-01-21       Impact factor: 5.130

2.  LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade.

Authors:  I Tanaka; H Osada; M Fujii; A Fukatsu; T Hida; Y Horio; Y Kondo; A Sato; Y Hasegawa; T Tsujimura; Y Sekido
Journal:  Oncogene       Date:  2013-12-16       Impact factor: 9.867

3.  Drosophila Ajuba is not an Aurora-A activator but is required to maintain Aurora-A at the centrosome.

Authors:  Dora Sabino; Nicholas H Brown; Renata Basto
Journal:  J Cell Sci       Date:  2011-04-01       Impact factor: 5.285

4.  Essential role of Wtip in mouse development and maintenance of the glomerular filtration barrier.

Authors:  Sethu M Madhavan; Martha Konieczkowski; Leslie A Bruggeman; Megan DeWalt; Jane K Nguyen; John F O'Toole; John R Sedor
Journal:  Am J Physiol Renal Physiol       Date:  2022-07-21

5.  Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis.

Authors:  Xingcheng Chen; Seth Stauffer; Yuanhong Chen; Jixin Dong
Journal:  J Biol Chem       Date:  2016-05-18       Impact factor: 5.157

6.  LIM-domain proteins TRIP6 and LPP associate with shelterin to mediate telomere protection.

Authors:  Samantha A Sheppard; Diego Loayza
Journal:  Aging (Albany NY)       Date:  2010-07       Impact factor: 5.682

7.  Kebab: kinetochore and EB1 associated basic protein that dynamically changes its localisation during Drosophila mitosis.

Authors:  Ana M Meireles; Nikola S Dzhindzhev; Hiroyuki Ohkura
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

8.  BubR1 Acts as a Promoter in Cellular Motility of Human Oral Squamous Cancer Cells through Regulating MMP-2 and MMP-9.

Authors:  Chou-Kit Chou; Chang-Yi Wu; Jeff Yi-Fu Chen; Ming-Chong Ng; Hui-Min David Wang; Jen-Hao Chen; Shyng-Shiou F Yuan; Eing-Mei Tsai; Jan-Gowth Chang; Chien-Chih Chiu
Journal:  Int J Mol Sci       Date:  2015-07-03       Impact factor: 5.923

Review 9.  Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins.

Authors:  Mar Carmena; Sandrine Ruchaud; William C Earnshaw
Journal:  Curr Opin Cell Biol       Date:  2009-12       Impact factor: 8.382

Review 10.  The Hippo Signaling Pathway in Cancer: A Cell Cycle Perspective.

Authors:  Yi Xiao; Jixin Dong
Journal:  Cancers (Basel)       Date:  2021-12-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.